Joben Bio-Medical Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 192.409 million compared to TWD 554.018 million a year ago. Operating loss was TWD 152.794 million compared to operating Income of TWD 73.485 million a year ago. Net loss was TWD 123.328 million compared to net income of TWD 60.658 million a year ago. Basic loss per share was TWD 2.02 compared to basic earnings per share of TWD 0.99 a year ago.